Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT-1: Influence on
Journal
Clinical and translational science
ISSN: 1752-8062
Titre abrégé: Clin Transl Sci
Pays: United States
ID NLM: 101474067
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
09
09
2020
accepted:
11
11
2020
pubmed:
6
12
2020
medline:
4
1
2022
entrez:
5
12
2020
Statut:
ppublish
Résumé
Positron emission tomography (PET) using 2-deoxy-2-[
Identifiants
pubmed: 33278334
doi: 10.1111/cts.12943
pmc: PMC8212708
doi:
Substances chimiques
Glucose Transporter Type 1
0
Protein Kinase Inhibitors
0
SLC2A1 protein, human
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
847-858Informations de copyright
© 2020 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics.
Références
Mol Cancer Ther. 2012 Sep;11(9):2033-44
pubmed: 22778153
Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E141-5
pubmed: 20009031
PLoS One. 2008;3(12):e3908
pubmed: 19079597
Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4711-6
pubmed: 27078104
Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):441-52
pubmed: 16450138
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Clin Cancer Res. 2005 Apr 15;11(8):2785-808
pubmed: 15837727
Biochem J. 1996 Apr 1;315 ( Pt 1):177-82
pubmed: 8670104
J Biol Chem. 2016 Dec 23;291(52):26762-26772
pubmed: 27836974
Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):431-56
pubmed: 26550536
J Biol Chem. 1977 Oct 25;252(20):7384-90
pubmed: 903365
ACS Chem Biol. 2016 Jul 15;11(7):1908-16
pubmed: 27128978
Br J Cancer. 2009 Jun 2;100(11):1739-45
pubmed: 19436299
J Oncol Pharm Pract. 2011 Sep;17(3):197-202
pubmed: 20685771
Oncologist. 2007 Apr;12(4):426-37
pubmed: 17470685
Physiol Rev. 1990 Oct;70(4):1135-76
pubmed: 2217557
Eur J Drug Metab Pharmacokinet. 2016 Jun;41(3):309-19
pubmed: 25656737
Clin Cancer Res. 2006 Oct 1;12(19):5659-67
pubmed: 17020967
Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1237-47
pubmed: 21360246
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):55-66
pubmed: 28361188
Nat Rev Cancer. 2007 May;7(5):345-56
pubmed: 17457302
Nature. 2014 Jun 5;510(7503):121-5
pubmed: 24847886
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
J Clin Oncol. 2002 Jan 15;20(2):379-87
pubmed: 11786564
J Thorac Oncol. 2010 Nov;5(11):1806-14
pubmed: 20881637
Am J Physiol Cell Physiol. 2015 May 15;308(10):C827-34
pubmed: 25715702
Transl Oncol. 2010 Aug 01;3(4):264-75
pubmed: 20689768
Cancer Res. 2005 Nov 1;65(21):9633-6
pubmed: 16266981
Clin Cancer Res. 2010 Sep 1;16(17):4434-45
pubmed: 20660574
J Nucl Med. 2009 Jul;50(7):1102-9
pubmed: 19525456
Nature. 2012 Oct 18;490(7420):361-6
pubmed: 23075985
Philos Trans R Soc Lond B Biol Sci. 1990 Jan 30;326(1236):391-410
pubmed: 1970645
Am J Nucl Med Mol Imaging. 2012;2(1):110-21
pubmed: 23133806
Pak J Pharm Sci. 2010 Jan;23(1):35-41
pubmed: 20067864
Angew Chem Int Ed Engl. 2019 Nov 25;58(48):17158-17162
pubmed: 31591797
Cancer Res. 2012 Oct 1;72(19):5014-24
pubmed: 22875026
Biochemistry. 2001 Jan 23;40(3):777-90
pubmed: 11170395
Am J Nucl Med Mol Imaging. 2012;2(3):353-61
pubmed: 23133822
Clin Cancer Res. 2008 Jun 1;14(11):3416-26
pubmed: 18519772
BMC Cancer. 2013 Apr 01;13:168
pubmed: 23548101
Clin Cancer Res. 2009 Jun 15;15(12):4220-7
pubmed: 19509175
Nat Rev Clin Oncol. 2017 May;14(5):268
pubmed: 28422115
Anticancer Res. 2006 Mar-Apr;26(2A):1247-52
pubmed: 16619531
Nat Med. 2006 Jan;12(1):122-7
pubmed: 16341243
PLoS One. 2015 Apr 28;10(4):e0125361
pubmed: 25919356
J Thorac Dis. 2019 May;11(Suppl 9):S1263-S1266
pubmed: 31245104